[HTML] sciencedirect.com

[HTML][HTML] Locoregional therapy in de novo metastatic breast cancer: systemic review and meta-analysis

D Reinhorn, R Mutai, R Yerushalmi, A Moore, E Amir… - The Breast, 2021 - Elsevier
Background Locoregional therapy (LRT) in de novo metastatic disease is controversial with
inconsistent results from randomized control trials (RCTs). Methods RCTs comparing LRT …
被引用次数：34 相关文章

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.

D Reinhorn, R Mutai, R Yerushalmi… - Breast (Edinburgh …, 2021 - europepmc.org
Background Locoregional therapy (LRT) in de novo metastatic disease is controversial with
inconsistent results from randomized control trials (RCTs). Methods RCTs comparing LRT …

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis

D Reinhorn, R Mutai, R Yerushalmi… - Breast (Edinburgh …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Locoregional therapy (LRT) in de novo metastatic disease is controversial with
inconsistent results from randomized control trials (RCTs). Methods RCTs comparing LRT …
[HTML] nih.gov

[HTML][HTML] Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis

D Reinhorn, R Mutai, R Yerushalmi… - The Breast: Official …, 2021 - ncbi.nlm.nih.gov
Background Locoregional therapy (LRT) in de novo metastatic disease is controversial with
inconsistent results from randomized control trials (RCTs). Methods RCTs comparing LRT …
[HTML] thebreastonline.com

[HTML][HTML] Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis

D Reinhorn, R Mutai, R Yerushalmi, A Moore… - The …, 2021 - thebreastonline.com
Background Locoregional therapy (LRT) in de novo metastatic disease is controversial with
inconsistent results from randomized control trials (RCTs). Methods RCTs comparing LRT …